Product information

Current status:

Cancelled Pre Market

Current status date:

2021-06-28

Original market date: ^{See footnote 1}

Product name:

NEOSTIGMINE METHYLSULFATE INJECTION

DIN:

02243103 Electronic product monograph is not available

Company:

FRESENIUS KABI CANADA LTD
165 Galaxy Blvd, Suite 100
Toronto
Ontario
Canada M9W 0C8

Class:

Human

Dosage form(s):

Liquid

Route(s) of administration:

Subcutaneous ,  Intramuscular ,  Intravenous

Number of active ingredient(s):

1

Schedule(s):

Prescription

American Hospital Formulary Service (AHFS): ^{See footnote 3}

12:04.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

N07AA01 NEOSTIGMINE

Active ingredient group (AIG) number:^{See footnote5}

0102263003